腰椎椎間板変性症市場- 世界の産業規模、シェア、動向、機会、予測、治療タイプ別、投与経路別、エンドユーザー別、地域別、競合別、2020-2030F

腰椎椎間板変性症の世界市場規模は2024年に90億6,000万米ドルとなり、予測期間には134億5,000万米ドルに達すると予測され、2030年までのCAGRは6.78%です。

腰椎椎間板変性症（DDD）の世界市場は、いくつかの重要な要因によって大きな成長と変貌を遂げています。腰椎DDDは、腰の椎間板が徐々に変性し、慢性的な痛み、運動能力の低下、生活の質の低下につながることを特徴とする、蔓延し衰弱させる疾患です。世界人口の高齢化が進み、座りっぱなしのライフスタイルが増えるにつれ、腰椎DDDの有病率は上昇傾向にあり、診断、治療、外科的介入に対する大きな市場が形成されています。

市場促進要因

人口の高齢化

主な市場課題

治療費の高騰

主な市場動向

手術技術の進歩

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界の腰椎椎間板変性症市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 治療の種類別（薬物治療、生物学的製剤、その他）
  • 投与経路別（経口、注射、その他）
  • エンドユーザー別（病院・診療所、外来診療センター、その他）
  • 地域別
  • 企業別（2024）
• 市場マップ
  • 治療の種類別
  • 投与経路別
  • エンドユーザー別
  • 地域別

第5章 アジア太平洋地域の腰椎椎間板変性症市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 治療の種類別
  • 投与経路別
  • エンドユーザー別
  • 国別
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • オーストラリア
  • 日本
  • 韓国

第6章 欧州の腰椎椎間板変性症市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • スペイン
  • イタリア
  • 英国

第7章 北米の腰椎椎間板変性症市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第8章 南米の腰椎椎間板変性症市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第9章 中東・アフリカの腰椎椎間板変性症市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第10章 市場力学

• 促進要因
• 課題

第11章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第12章 世界の腰椎椎間板変性症市場：SWOT分析

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• Sorrento Therapeutics
• Spine Thera
• Eliem Therapeutics
• Scilex Holding
• Sinfonia Biotherapeutics
• Seikagaku Corporation
• Kolon life Science
• Vita Sciences
• Aurobindo Pharma
• Le Neurotech

第15章 戦略的提言

第16章 調査会社について・免責事項

Global Lumbar Degenerative Disc Disease Market was valued at USD 9.06 Billion in 2024 and is expected to reach USD 13.45 Billion in the forecast period with a CAGR of 6.78% through 2030. The global market for Lumbar Degenerative Disc Disease (DDD) is experiencing significant growth and transformation due to several key factors. Lumbar DDD is a prevalent and debilitating condition characterized by the gradual degeneration of intervertebral discs in the lower back, leading to chronic pain, reduced mobility, and decreased quality of life. As the world's population continues to age and lifestyles become increasingly sedentary, the prevalence of Lumbar DDD is on the rise, creating a substantial market for diagnostic, therapeutic, and surgical interventions.

Key Market Drivers

Aging Population

The aging population is a significant driver behind the growth of the Global Lumbar Degenerative Disc Disease (DDD) Market. Lumbar DDD, characterized by the gradual deterioration of intervertebral discs in the lower back, becomes increasingly prevalent with age. As the global demographic shifts toward older age groups, the incidence of Lumbar DDD is rising. For instance, in the United States, the population aged 65 and over grew from 40.3 million in 2010 to 55.8 million in 2020, a 38.6% increase, accounting for 16.8% of the total population. This trend is particularly prominent in developed countries where life expectancy has increased due to advancements in healthcare and living standards.

As individuals age, natural wear and tear on spinal discs become more pronounced, increasing susceptibility to Lumbar DDD. Studies have shown that one-third of people aged 40-59 have evidence of degenerative disc disease. This age-related degeneration can lead to chronic back pain, reduced mobility, and diminished quality of life. Consequently, there is a growing demand for medical interventions and treatments to address the symptoms and complications associated with Lumbar DDD among the elderly. Healthcare providers are witnessing a surge in older patients seeking diagnosis and treatment for Lumbar DDD, leading to increased awareness and the development of innovative therapies tailored to aging individuals. Additionally, older patients are more likely to undergo surgical procedures to manage severe cases of Lumbar DDD, further fueling the market's growth in surgical techniques and implantable devices.

Key Market Challenges

High Cost of Treatment

The cost of treating Lumbar DDD can be substantial, often encompassing a range of expenses, including diagnostic tests, physician consultations, physical therapy, medications, and, in some cases, surgical procedures. For many patients, especially those without comprehensive health insurance coverage, these costs can lead to a substantial financial burden. The prospect of high out-of-pocket expenses can deter individuals from seeking medical attention promptly, leading to delayed diagnosis and treatment. The high cost of treatment exacerbates healthcare disparities, making access to care unequal. Low-income individuals and those without adequate insurance coverage are particularly vulnerable. These disparities can result in unequal access to diagnostic tools, specialized consultations, and advanced treatments for Lumbar DDD. In essence, the cost barrier creates a divide in the quality of care received by patients, depending on their financial resources.

Delayed diagnosis and treatment due to financial concerns can have severe consequences for Lumbar DDD patients. This condition often worsens over time, leading to increased pain, reduced mobility, and a decreased quality of life. Delayed intervention can result in the progression of the disease to more severe stages, necessitating more extensive and costly treatments in the long run.

Key Market Trends

Advancements in Surgical Techniques

Advancements in surgical techniques have emerged as a pivotal factor propelling the growth of the Global Lumbar Degenerative Disc Disease (DDD) Market. Lumbar DDD, characterized by the deterioration of intervertebral discs in the lower back, can cause excruciating pain and severely compromise an individual's quality of life. However, recent strides in surgical approaches have revolutionized the field of Lumbar DDD treatment, offering patients safer, more effective, and less invasive options. Procedures such as spinal fusion and artificial disc replacement have seen remarkable advancements, making them increasingly attractive treatment choices. These surgical techniques have become safer, thanks to improved instrumentation and surgical tools that enhance precision and reduce the risk of complications. Surgeons now have access to innovative implants, including artificial discs and bone graft substitutes, which have significantly improved patient outcomes by replicating the natural biomechanics of the spine.

Moreover, the minimally invasive approach to Lumbar DDD surgery is gaining prominence. Minimally invasive surgery entails smaller incisions, reduced muscle disruption, and shorter recovery times compared to traditional open procedures. Techniques like endoscopic discectomy and laser-assisted surgery have made Lumbar DDD treatments more patient-friendly, as they minimize postoperative discomfort and hospital stays. Patients can often return to their daily activities more quickly, contributing to a higher quality of life.

Key Market Players

• Sorrento Therapeutics
• Spine Thera
• Eliem Therapeuticsa
• Scilex Holding
• Sinfonia Biotherapeutics
• Seikagaku Corporation
• Kolon life Science
• Vita Sciences
• Aurobindo Pharma
• Le Neurotech

Report Scope:

In this report, the Global Lumbar Degenerative Disc Disease Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Lumbar Degenerative Disc Disease Market, By Treatment Type:

• Drug Treatment
• Biologics
• Other

Lumbar Degenerative Disc Disease Market, By Route of administration:

• Oral
• Injectables
• Other

Lumbar Degenerative Disc Disease Market, By End User:

• Hospitals & Clinics
• Ambulatory Care Centers
• Others

Lumbar Degenerative Disc Disease Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Lumbar Degenerative Disc Disease Market.

Available Customizations:

Global Lumbar Degenerative Disc Disease market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Lumbar Degenerative Disc Disease Market Outlook

• 4.1. Market Size & Forecast
  • 4.1.1. By Value
• 4.2. Market Share & Forecast
  • 4.2.1. By Treatment Type (Drug Treatment, Biologics, Other)
  • 4.2.2. By Route of administration (Oral, Injectables, Other)
  • 4.2.3. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
  • 4.2.4. By Region
  • 4.2.5. By Company (2024)
• 4.3. Market Map
  • 4.3.1. By Treatment Type
  • 4.3.2. By Route of administration
  • 4.3.3. By End User
  • 4.3.4. By Region

5. Asia Pacific Lumbar Degenerative Disc Disease Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Treatment Type
  • 5.2.2. By Route of administration
  • 5.2.3. By End User
  • 5.2.4. By Country
• 5.3. Asia Pacific: Country Analysis
  • 5.3.1. China Lumbar Degenerative Disc Disease Market Outlook
    • 5.3.1.1. Market Size & Forecast
      • 5.3.1.1.1. By Value
    • 5.3.1.2. Market Share & Forecast
      • 5.3.1.2.1. By Treatment Type
      • 5.3.1.2.2. By Route of administration
      • 5.3.1.2.3. By End User
  • 5.3.2. India Lumbar Degenerative Disc Disease Market Outlook
    • 5.3.2.1. Market Size & Forecast
      • 5.3.2.1.1. By Value
    • 5.3.2.2. Market Share & Forecast
      • 5.3.2.2.1. By Treatment Type
      • 5.3.2.2.2. By Route of administration
      • 5.3.2.2.3. By End User
  • 5.3.3. Australia Lumbar Degenerative Disc Disease Market Outlook
    • 5.3.3.1. Market Size & Forecast
      • 5.3.3.1.1. By Value
    • 5.3.3.2. Market Share & Forecast
      • 5.3.3.2.1. By Treatment Type
      • 5.3.3.2.2. By Route of administration
      • 5.3.3.2.3. By End User
  • 5.3.4. Japan Lumbar Degenerative Disc Disease Market Outlook
    • 5.3.4.1. Market Size & Forecast
      • 5.3.4.1.1. By Value
    • 5.3.4.2. Market Share & Forecast
      • 5.3.4.2.1. By Treatment Type
      • 5.3.4.2.2. By Route of administration
      • 5.3.4.2.3. By End User
  • 5.3.5. South Korea Lumbar Degenerative Disc Disease Market Outlook
    • 5.3.5.1. Market Size & Forecast
      • 5.3.5.1.1. By Value
    • 5.3.5.2. Market Share & Forecast
      • 5.3.5.2.1. By Treatment Type
      • 5.3.5.2.2. By Route of administration
      • 5.3.5.2.3. By End User

6. Europe Lumbar Degenerative Disc Disease Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Treatment Type
  • 6.2.2. By Route of administration
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. Europe: Country Analysis
  • 6.3.1. France Lumbar Degenerative Disc Disease Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Treatment Type
      • 6.3.1.2.2. By Route of administration
      • 6.3.1.2.3. By End User
  • 6.3.2. Germany Lumbar Degenerative Disc Disease Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Treatment Type
      • 6.3.2.2.2. By Route of administration
      • 6.3.2.2.3. By End User
  • 6.3.3. Spain Lumbar Degenerative Disc Disease Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Treatment Type
      • 6.3.3.2.2. By Route of administration
      • 6.3.3.2.3. By End User
  • 6.3.4. Italy Lumbar Degenerative Disc Disease Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Treatment Type
      • 6.3.4.2.2. By Route of administration
      • 6.3.4.2.3. By End User
  • 6.3.5. United Kingdom Lumbar Degenerative Disc Disease Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Treatment Type
      • 6.3.5.2.2. By Route of administration
      • 6.3.5.2.3. By End User

7. North America Lumbar Degenerative Disc Disease Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Treatment Type
  • 7.2.2. By Route of administration
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. North America: Country Analysis
  • 7.3.1. United States Lumbar Degenerative Disc Disease Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Treatment Type
      • 7.3.1.2.2. By Route of administration
      • 7.3.1.2.3. By End User
  • 7.3.2. Mexico Lumbar Degenerative Disc Disease Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Treatment Type
      • 7.3.2.2.2. By Route of administration
      • 7.3.2.2.3. By End User
  • 7.3.3. Canada Lumbar Degenerative Disc Disease Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Treatment Type
      • 7.3.3.2.2. By Route of administration
      • 7.3.3.2.3. By End User

8. South America Lumbar Degenerative Disc Disease Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Treatment Type
  • 8.2.2. By Route of administration
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. South America: Country Analysis
  • 8.3.1. Brazil Lumbar Degenerative Disc Disease Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Treatment Type
      • 8.3.1.2.2. By Route of administration
      • 8.3.1.2.3. By End User
  • 8.3.2. Argentina Lumbar Degenerative Disc Disease Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Treatment Type
      • 8.3.2.2.2. By Route of administration
      • 8.3.2.2.3. By End User
  • 8.3.3. Colombia Lumbar Degenerative Disc Disease Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Treatment Type
      • 8.3.3.2.2. By Route of administration
      • 8.3.3.2.3. By End User

9. Middle East and Africa Lumbar Degenerative Disc Disease Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Treatment Type
  • 9.2.2. By Route of administration
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. MEA: Country Analysis
  • 9.3.1. South Africa Lumbar Degenerative Disc Disease Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Treatment Type
      • 9.3.1.2.2. By Route of administration
      • 9.3.1.2.3. By End User
  • 9.3.2. Saudi Arabia Lumbar Degenerative Disc Disease Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Treatment Type
      • 9.3.2.2.2. By Route of administration
      • 9.3.2.2.3. By End User
  • 9.3.3. UAE Lumbar Degenerative Disc Disease Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Treatment Type
      • 9.3.3.2.2. By Route of administration
      • 9.3.3.2.3. By End User

10. Market Dynamics

• 10.1. Drivers
• 10.2. Challenges

11. Market Trends & Developments

• 11.1. Recent Developments
• 11.2. Product Launches
• 11.3. Mergers & Acquisitions

12. Global Lumbar Degenerative Disc Disease Market: SWOT Analysis

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Product

14. Competitive Landscape

• 14.1. Sorrento Therapeutics
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Current Capacity Analysis
  • 14.1.5. Financials (In case of listed)
  • 14.1.6. Recent Developments
  • 14.1.7. SWOT Analysis
• 14.2. Spine Thera
• 14.3. Eliem Therapeutics
• 14.4. Scilex Holding
• 14.5. Sinfonia Biotherapeutics
• 14.6. Seikagaku Corporation
• 14.7. Kolon life Science
• 14.8. Vita Sciences
• 14.9. Aurobindo Pharma
• 14.10. Le Neurotech

15. Strategic Recommendations

16. About Us & Disclaimer